Imprimis NJOF, LLC recalls Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compo
Recalled June 19, 2024 · FDA recall D-0548-2024 · Imprimis NJOF
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
4,280 boxes
Sold at
US Nationwide
Description
Lack of Assurance of Sterility
Product
Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compounded by: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ NDC 71384-310-05
Manufacturer(s)
Imprimis NJOF, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →